Immunotherapy in Acute Leukemias
No contributors found.
Release Date: 2024-06-12
Immunotherapeutic agents have made remarkable progress in the treatment of acute leukemia. CAR T cell therapy, particularly CD19 and BCMA-targeted CAR-T cells, has shown promising results with high response rates and long remission durations. However, these therapies can be challenging to manage and may present serious toxicities, requiring careful monitoring. Despite the challenges in AML [...]
